455 related articles for article (PubMed ID: 16855129)
1. Preference-Based EQ-5D index scores for chronic conditions in the United States.
Sullivan PW; Ghushchyan V
Med Decis Making; 2006; 26(4):410-20. PubMed ID: 16855129
[TBL] [Abstract][Full Text] [Related]
2. Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample.
Sullivan PW; Ghushchyan V
Med Decis Making; 2006; 26(4):401-9. PubMed ID: 16855128
[TBL] [Abstract][Full Text] [Related]
3. Catalogue of EQ-5D scores for the United Kingdom.
Sullivan PW; Slejko JF; Sculpher MJ; Ghushchyan V
Med Decis Making; 2011; 31(6):800-4. PubMed ID: 21422468
[TBL] [Abstract][Full Text] [Related]
4. A national catalog of preference-based scores for chronic conditions in the United States.
Sullivan PW; Lawrence WF; Ghushchyan V
Med Care; 2005 Jul; 43(7):736-49. PubMed ID: 15970790
[TBL] [Abstract][Full Text] [Related]
5. EQ-5D Scores for Diabetes-Related Comorbidities.
Sullivan PW; Ghushchyan VH
Value Health; 2016 Dec; 19(8):1002-1008. PubMed ID: 27987626
[TBL] [Abstract][Full Text] [Related]
6. Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: toward consistency in cost-effectiveness analyses.
Franks P; Hanmer J; Fryback DG
Med Care; 2006 May; 44(5):478-85. PubMed ID: 16641667
[TBL] [Abstract][Full Text] [Related]
7. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
8. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
Jia H; Zack MM; Moriarty DG; Fryback DG
Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
[TBL] [Abstract][Full Text] [Related]
9. The impact of co-morbidity burden on preference-based health-related quality of life in the United States.
Sullivan PW; Ghushchyan VH; Bayliss EA
Pharmacoeconomics; 2012 May; 30(5):431-42. PubMed ID: 22452633
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
11. Estimating EuroQol EQ-5D scores from Population Healthy Days data.
Jia H; Lubetkin EI
Med Decis Making; 2008; 28(4):491-9. PubMed ID: 18556640
[TBL] [Abstract][Full Text] [Related]
12. Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample.
Lawrence WF; Fleishman JA
Med Decis Making; 2004; 24(2):160-9. PubMed ID: 15090102
[TBL] [Abstract][Full Text] [Related]
13. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
[TBL] [Abstract][Full Text] [Related]
14. A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea.
Kang EJ; Ko SK
Value Health; 2009; 12 Suppl 3():S114-7. PubMed ID: 20586972
[TBL] [Abstract][Full Text] [Related]
15. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
Park SJ; Ahn S; Woo SJ; Park KH
JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
[TBL] [Abstract][Full Text] [Related]
16. Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics.
Nyman JA; Barleen NA; Dowd BE; Russell DW; Coons SJ; Sullivan PW
Med Care; 2007 Jul; 45(7):618-28. PubMed ID: 17571010
[TBL] [Abstract][Full Text] [Related]
17. Utilities should not be multiplied: evidence from the preference-based scores in the United States.
Fu AZ; Kattan MW
Med Care; 2008 Sep; 46(9):984-90. PubMed ID: 18725854
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive catalogue of EQ-5D scores in chronic disease: results of a systematic review.
Van Wilder L; Rammant E; Clays E; Devleesschauwer B; Pauwels N; De Smedt D
Qual Life Res; 2019 Dec; 28(12):3153-3161. PubMed ID: 31531840
[TBL] [Abstract][Full Text] [Related]
19. United States Valuation of EQ-5D-5L Health States Using an International Protocol.
Pickard AS; Law EH; Jiang R; Pullenayegum E; Shaw JW; Xie F; Oppe M; Boye KS; Chapman RH; Gong CL; Balch A; Busschbach JJV
Value Health; 2019 Aug; 22(8):931-941. PubMed ID: 31426935
[TBL] [Abstract][Full Text] [Related]
20. Preference weights for the spectrum of alcohol use in the U.S. Population.
Chavez LJ; Bradley K; Tefft N; Liu CF; Hebert P; Devine B
Drug Alcohol Depend; 2016 Apr; 161():206-13. PubMed ID: 26900145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
